0

ADAGEN از شرکت LEADIANT BIOSCI INC

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

ADAGEN از شرکت LEADIANT BIOSCI INC

Biologic License Application (BLA): 019818

Company: LEADIANT BIOSCI INC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ADAGEN PEGADEMASE BOVINE 250 UNITS/ML INJECTABLE;INJECTION Discontinued

None

No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/21/1990 ORIG-1 Approval

N/A; Orphan

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/21/2015 SUPPL-56 Supplement

Label is not available on this site.

07/17/2014 SUPPL-55 Supplement

Label is not available on this site.

06/05/2014 SUPPL-53 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019818s053lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/019818Orig1s053ltr.pdf

03/04/2014 SUPPL-52 Supplement

Label is not available on this site.

12/17/2013 SUPPL-51 Supplement

Label is not available on this site.

01/10/2014 SUPPL-50 Supplement

Label is not available on this site.

10/15/2013 SUPPL-48 Supplement

Label is not available on this site.

10/07/2013 SUPPL-47 Supplement

Label is not available on this site.

01/15/2013 SUPPL-46 Supplement

Label is not available on this site.

09/25/2008 SUPPL-42 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019818s042lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/019818s042ltr.pdf

10/26/2007 SUPPL-34 Supplement

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019818s034lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/019818s034ltr.pdf

04/15/2002 SUPPL-24 Supplement

Label is not available on this site.

08/17/2001 SUPPL-23 Supplement

Label is not available on this site.

09/16/1998 SUPPL-17 Supplement

Label is not available on this site.

12/06/1993 SUPPL-14 Supplement

Label is not available on this site.

06/16/1994 SUPPL-13 Supplement

Label is not available on this site.

08/11/1993 SUPPL-11 Supplement

Label is not available on this site.

11/10/1992 SUPPL-9 Supplement

Label is not available on this site.

12/28/1992 SUPPL-8 Supplement

Label is not available on this site.

03/09/1993 SUPPL-7 Supplement

Label is not available on this site.

04/22/1992 SUPPL-5 Supplement

Label is not available on this site.

04/13/1992 SUPPL-4 Supplement

Label is not available on this site.

09/27/1991 SUPPL-3 Supplement

Label is not available on this site.

06/10/1991 SUPPL-2 Supplement

Label is not available on this site.

11/28/1990 SUPPL-1 Supplement

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
06/05/2014 SUPPL-53

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019818s053lbl.pdf
09/25/2008 SUPPL-42

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019818s042lbl.pdf
10/26/2007 SUPPL-34

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019818s034lbl.pdf
حتما بخوانید : BUMETANIDE از شرکت HOSPIRA
بخوانید  ACETAZOLAMIDE از شرکت APPCO
برچسب‌ها:

نظرات کاربران